Viromed Medical AG (ETR:VME)
Germany · Delayed Price · Currency is EUR 6.50
0.00 (0.00%)
Last updated: Aug 26, 2026, 9:18 AM CET
Viromed Medical AG Balance Sheet
Financials in millions EUR. Fiscal year is January - December.
Millions EUR. Fiscal year is Jan - Dec.
Assets
Fiscal Year | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|
Period Ending | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Cash & Equivalents | 0.36 | 0.02 | 0.2 | 0.15 | 0.25 |
Short-Term Investments | 0 | 0 | - | - | - |
Cash & Short-Term Investments | 0.36 | 0.02 | 0.2 | 0.15 | 0.25 |
Cash Growth | 1391.18% | -87.50% | 29.78% | -39.04% | - |
Receivables | 1.12 | 0.14 | - | - | - |
Inventory | 0.72 | 0.37 | - | - | - |
Prepaid Expenses | 0.1 | 0.06 | 0.02 | 0 | - |
Other Current Assets | 3.36 | 8.71 | 0.01 | - | - |
Total Current Assets | 10.04 | 12.39 | 0.23 | 0.15 | 0.25 |
Property, Plant & Equipment | 1.26 | 0.12 | - | - | - |
Long-Term Investments | - | 0.01 | 20.1 | 20.1 | - |
Goodwill | 2.47 | - | - | - | - |
Other Intangible Assets | 0.1 | 0.85 | - | - | - |
Other Long-Term Assets | 0.04 | 0.03 | - | 0 | - |
Total Assets | 13.91 | 13.4 | 20.33 | 20.26 | 0.25 |
Liabilities
Fiscal Year | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|
Period Ending | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Accounts Payable | 1.2 | 0.57 | 0.08 | 0.08 | - |
Accrued Expenses | 0 | 0 | - | - | - |
Current Portion of Long-Term Debt | 0.01 | 0.01 | - | - | - |
Current Income Taxes Payable | 0.08 | 1.47 | - | - | - |
Other Current Liabilities | 0.78 | 0.81 | - | - | - |
Total Current Liabilities | 2.07 | 2.86 | 0.08 | 0.08 | - |
Other Long-Term Liabilities | 1.37 | 3.32 | 0.27 | 0.09 | 0 |
Total Liabilities | 3.44 | 6.18 | 0.36 | 0.17 | 0 |
Shareholders' Equity
Fiscal Year | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|
Period Ending | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Common Stock | 21.25 | 20.25 | 20.25 | 20.25 | 0.25 |
Retained Earnings | -12.23 | -12.92 | -0.28 | -0.17 | -0.01 |
Treasury Stock | -0.04 | -0.1 | - | - | - |
Comprehensive Income & Other | 1.5 | - | - | - | - |
Shareholders' Equity | 10.47 | 7.22 | 19.97 | 20.08 | 0.24 |
Total Liabilities & Equity | 13.91 | 13.4 | 20.33 | 20.26 | 0.25 |
Additional Metrics
Fiscal Year | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|
Period Ending | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Total Debt | 0.01 | 0.01 | - | - | - |
Net Cash (Debt) | 0.36 | 0.01 | 0.2 | 0.15 | 0.25 |
Net Cash Growth | 2637.35% | -93.35% | 29.78% | -39.04% | - |
Net Cash Per Share | 0.02 | 0.00 | 0.01 | 0.01 | - |
Filing Date Shares Outstanding | 21.25 | 20.25 | 20.25 | 20.25 | - |
Total Common Shares Outstanding | 21.25 | 20.25 | 20.25 | 20.25 | - |
Working Capital | 7.97 | 9.53 | 0.14 | 0.07 | 0.25 |
Book Value Per Share | 0.49 | 0.36 | 0.99 | 0.99 | - |
Tangible Book Value | 7.9 | 6.37 | 19.97 | 20.08 | 0.24 |
Tangible Book Value Per Share | 0.37 | 0.31 | 0.99 | 0.99 | - |
Machinery | 1.15 | 0.05 | - | - | - |